• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[遗传性甲状腺髓样癌]

[Hereditary medullary thyroid cancer].

作者信息

Fendrich V, Zahn A

机构信息

Klinik für Endokrine Chirurgie, Schön Klinik Eilbek, Dehnhaide 120, 22081, Hamburg, Deutschland.

出版信息

Chirurgie (Heidelb). 2023 May;94(5):393-399. doi: 10.1007/s00104-023-01824-x. Epub 2023 Feb 17.

DOI:10.1007/s00104-023-01824-x
PMID:36799965
Abstract

Parafollicular C cells progress via C cell hyperplasia to medullary thyroid cancer (MTC), which can be present even in the first years of life in multiple endocrine neoplasia (MEN) type 2A and 2B patients. Basal calcitonin and carcinoembryonic antigen (CEA) are useful tumor markers for the diagnosis and monitoring. The prognosis depends on the stage when the disease is diagnosed and there is a good genotype-phenotype correlation with the RET proto-oncogene, which can be used for estimation of the risk. The risk-stratified prophylactic thyroidectomy plays a decisive role in the prognosis of known gene mutation carriers.

摘要

甲状腺滤泡旁C细胞通过C细胞增生发展为甲状腺髓样癌(MTC),在多发性内分泌腺瘤(MEN)2A和2B型患者中,甚至在生命的最初几年就可能出现。基础降钙素和癌胚抗原(CEA)是诊断和监测的有用肿瘤标志物。预后取决于疾病诊断时的阶段,并且与RET原癌基因存在良好的基因型-表型相关性,可用于风险评估。风险分层的预防性甲状腺切除术在已知基因突变携带者的预后中起决定性作用。

相似文献

1
[Hereditary medullary thyroid cancer].[遗传性甲状腺髓样癌]
Chirurgie (Heidelb). 2023 May;94(5):393-399. doi: 10.1007/s00104-023-01824-x. Epub 2023 Feb 17.
2
Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.早期检测RET原癌基因突变对于2型多发性内分泌腺瘤病患儿的预防性甲状腺切除术至关重要:无症状携带者中存在C细胞恶性疾病。
Cancer. 2002 Jan 15;94(2):323-30. doi: 10.1002/cncr.10228.
3
A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.挪威2A型多发性内分泌腺瘤病的全国性研究:甲状腺髓样癌临床病程的预测和预后因素
Thyroid. 2016 Sep;26(9):1225-38. doi: 10.1089/thy.2015.0673. Epub 2016 Aug 11.
4
Critically evaluated key points on hereditary medullary thyroid carcinoma.对遗传性髓样甲状腺癌的关键点进行了批判性评估。
Front Endocrinol (Lausanne). 2024 Jun 11;15:1412942. doi: 10.3389/fendo.2024.1412942. eCollection 2024.
5
Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.RET原癌基因分析对2型多发性内分泌腺瘤临床管理的影响
Clinics (Sao Paulo). 2006 Feb;61(1):59-70. Epub 2006 Mar 10.
6
Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.基于中国 RET 原癌基因突变和基础降钙素检测对 MEN2 相关甲状腺髓样癌的预防性甲状腺切除术。
Eur J Surg Oncol. 2013 Sep;39(9):1007-12. doi: 10.1016/j.ejso.2013.06.015. Epub 2013 Jul 9.
7
[30 years of prophylactic thyroidectomy for hereditary medullary thyroid cancer : A milestone in translational medicine].遗传性甲状腺髓样癌预防性甲状腺切除术30年:转化医学的一个里程碑
Chirurgie (Heidelb). 2024 Aug;95(8):638-650. doi: 10.1007/s00104-024-02105-x. Epub 2024 May 28.
8
Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).遗传性 C 细胞疾病基因携带者甲状腺手术的时机和范围——欧洲内分泌外科学会(ESES)的共识声明。
Langenbecks Arch Surg. 2014 Feb;399(2):185-97. doi: 10.1007/s00423-013-1139-5. Epub 2013 Dec 3.
9
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.遗传性和散发性甲状腺髓样癌的基因诊断的临床实用性。
Ann Endocrinol (Paris). 2019 Jun;80(3):187-190. doi: 10.1016/j.ando.2019.04.014. Epub 2019 Apr 11.
10
[Familial medullary thyroid carcinoma: case report and literature review.].[家族性甲状腺髓样癌:病例报告及文献综述。]
Rev Fac Cien Med Univ Nac Cordoba. 2018 Dec 12;75(4):303-309. doi: 10.31053/1853.0605.v75.n4.20947.

本文引用的文献

1
Superiority of continuous over intermittent intraoperative nerve monitoring in preventing vocal cord palsy.连续术中神经监测优于间断术中神经监测,可预防声带麻痹。
Br J Surg. 2021 May 27;108(5):566-573. doi: 10.1002/bjs.11901.
2
[Systemic treatment of metastasized thyroid cancer-approved treatments and new approaches].[转移性甲状腺癌的系统治疗——批准的治疗方法和新途径]
Chirurg. 2020 Dec;91(12):1038-1043. doi: 10.1007/s00104-020-01284-7.
3
Modern surgery for advanced thyroid cancer: a tailored approach.晚期甲状腺癌的现代外科治疗:一种个体化治疗方法。
Gland Surg. 2020 Feb;9(Suppl 2):S105-S119. doi: 10.21037/gs.2019.12.16.
4
100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A.2A 型多发性内分泌腺瘤病的精准医学与手术的百年演进
Endocrine. 2020 May;68(2):368-376. doi: 10.1007/s12020-020-02232-5. Epub 2020 Feb 25.
5
Calcitonin as a biomarker of C cell disease: recent achievements and current challenges.降钙素作为C细胞疾病的生物标志物:近期成果与当前挑战
Endocrine. 2020 Feb;67(2):273-280. doi: 10.1007/s12020-019-02183-6. Epub 2020 Jan 10.
6
Long-term outcome after DNA-based prophylactic neck surgery in children at risk of hereditary medullary thyroid cancer.基于 DNA 的预防性颈部手术治疗遗传性髓样甲状腺癌高危儿童的长期疗效。
Best Pract Res Clin Endocrinol Metab. 2019 Aug;33(4):101274. doi: 10.1016/j.beem.2019.04.008. Epub 2019 Apr 17.
7
Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.手术治疗阴性和阳性淋巴结髓样甲状腺癌后降钙素正常化的时间。
Br J Surg. 2019 Mar;106(4):412-418. doi: 10.1002/bjs.11071. Epub 2019 Feb 6.
8
Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma.2型多发性内分泌腺瘤病的最新进展:聚焦甲状腺髓样癌
J Endocr Soc. 2018 Jul 13;2(8):933-943. doi: 10.1210/js.2018-00178. eCollection 2018 Aug 1.
9
Comparison of 68Ga PET/CT to Other Imaging Studies in Medullary Thyroid Cancer: Superiority in Detecting Bone Metastases.68Ga PET/CT 与其他影像学研究在甲状腺髓样癌中的比较:在检测骨转移方面具有优势。
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3250-3259. doi: 10.1210/jc.2018-00193.
10
65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicine.65 年的双螺旋:从 RET 受体中挖掘个性化癌症药物的见解。
Endocr Relat Cancer. 2018 Aug;25(8):T189-T200. doi: 10.1530/ERC-18-0141. Epub 2018 May 9.